Holen Sie sich die Stockscreener-App
19.23
0.63%
0.11
Omeros Corp Aktie (OMER) Neueste Nachrichten
OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits
Omeros Stock Price Forecast. Should You Buy OMER? - StockInvest.us
Omeros Corp VP and General Counsel Peter B. Cancelmo Executes Stock Option Exercises and Sells Shares - Kalkine Media
Omeros Insider Sold Shares Worth $929,668, According to a Recent SEC Filing - marketscreener.com
Omeros VP, finance & CAO David Borges sells $206,804 in shares By Investing.com - Investing.com South Africa
Omeros VP, finance & CAO David Borges sells $206,804 in shares - Investing.com Nigeria
Omeros VP of finance David Borges sells $206,804 in shares By Investing.com - Investing.com Nigeria
Omeros VP of finance David Borges sells $206,804 in shares - Investing.com
Omeros Corp (OMER) Director Thomas Cable Sells 15,000 Shares - GuruFocus
Omeros director Thomas Cable sells $276,772 in company stock - Investing.com
Omeros director Thomas Cable sells $276,772 in company stock By Investing.com - Investing.com Canada
Omeros (NASDAQ:OMER) Director Thomas Cable Sells 15,000 Shares - MarketBeat
Omeros (NASDAQ: OMER) officer to sell 10,906 shares - Stock Titan
Omeros Corp (OMER) director lines up fresh stock sale - Stock Titan
Pomerantz investigates Omeros after CHMP negative opinion - scanx.trade
Omeros (NASDAQ:OMER) Sets New 52-Week HighStill a Buy? - MarketBeat
Omeros stock hits 52-week high at 18.16 USD - Investing.com
Omeros stock hits 52-week high at 18.16 USD By Investing.com - Investing.com Canada
Omeros Corp (OMER) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Omeros Corp (HAM:3O8) Stock Price, Trades & News - GuruFocus
Omeros VP, finance & CAO Borges sells $84,750 in shares - Investing.com India
Omeros VP, finance & CAO Borges sells $84,750 in shares By Investing.com - Investing.com South Africa
Omeros (NASDAQ:OMER) CAO David Borges Sells 5,000 Shares of Stock - MarketBeat
HC Wainwright Comments on Omeros' Q3 Earnings (NASDAQ:OMER) - MarketBeat
OMER Stock On Track For Best Week In Nearly 4 Months After Receiving Permanent Reimbursement Code For Treatment - Stocktwits
Teleconferência de Resultados do 2T26 da Omeros (OMER): Vendas do YARTEMLEA Atingem US$ 28,5 Milhões - TradingKey
Wall Street Zen Upgrades Omeros (NASDAQ:OMER) to Buy - MarketBeat
Omeros Corporation (NASDAQ:OMER) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Omeros (OMER) Turns Profitable As Investors Ask If The Repricing Has Gone Too Far - Yahoo Finance
Omeros Corporation Releases Q2 2026 Earnings Call Summary as Pipeline Development Remains in Focus - Vinanet
What is HC Wainwright's Forecast for Omeros FY2029 Earnings? - MarketBeat
Omeros Corporation $OMER Shares Purchased by Dimensional Fund Advisors LP - MarketBeat
OMER|Omeros Corp|Price:17.190|Chg%:-0.160 - TradingKey
OMER SWOT Analysis: Key Insights from the 10-Q Filing - GuruFocus
OMEROS CORP SEC Filing (Aug 13, 2026) - Stock Titan
Omeros Corporation Announces Appointment of Joseph Schocken as Director and Audit Committee Member, Effective August 12, 2026 - marketscreener.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Biotech Stocks To ConsiderAugust 13th - MarketBeat
Omeros Sees Unusually Large Options Volume (NASDAQ:OMER) - MarketBeat
Omeros (NASDAQ:OMER) Sets New 52-Week High Following Better-Than-Expected Earnings - MarketBeat
Omeros Corp (OMER) Shares Surge 29% on Q2 Beat; Price-to-Sales V - GuruFocus
Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday - Benzinga
Why is Omeros stock surging today? By Investing.com - Investing.com South Africa
Why is Omeros stock surging today? - Investing.com
Omeros Corp (OMER) Shares Surge 15% on Q2 Boost; Price-to-Sales Valuation Raises Growth Expectations - GuruFocus
Why Omeros Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Omeros Q2 2026 Earnings Call Transcript - marketbeat.com
Portnoy Law Firm investigates Omeros after CHMP negative opinion - scanx.trade
Omeros Corp (OMER) Posts $28.5M Net Sales for YARTEMLEA's Debut Quarter Amid Valuation Concerns - GuruFocus
Omeros Corp Swings To Q2 Profit On YARTEMLEA Momentum; Plans ARDS, TA-TMA Studies; Shares Rise - RTTNews
Omeros Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Omeros faces CHMP rejection for narsoplimab in TA-TMA - scanx.trade
Omeros Q2 Earnings Call Highlights - MarketBeat
Omeros Q2 Results: Adj. EPS $0.02 beats $(0.27) estimate - scanx.trade
Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $0.29 EPS - MarketBeat
0.28%
4.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):